 | • レポートコード：MRC2102QY1934 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のバイオシミラー市場について種類別（組換え非グリコシル化タンパク質（インスリン、rHGH、インターフェロン）、グリコシル化（mAb、EPO）、ペプチド（グルカゴン、カルシトニン）、ペプチド（グルカゴン、カルシトニン））、用途別（腫瘍学、造血系疾患）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・バイオシミラー市場の概要 ・世界の主要地域別バイオシミラー市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のバイオシミラー市場規模2015-2026：種類別（組換え非グリコシル化タンパク質（インスリン、rHGH、インターフェロン）、グリコシル化（mAb、EPO）、ペプチド（グルカゴン、カルシトニン）、ペプチド（グルカゴン、カルシトニン）） ・世界のバイオシミラー市場規模2015-2026：用途別（腫瘍学、造血系疾患） ・バイオシミラーの米国市場規模2015-2020 ・バイオシミラーのヨーロッパ市場規模2015-2020 ・バイオシミラーの中国市場規模2015-2020 ・バイオシミラーの日本市場規模2015-2020 ・バイオシミラーの東南アジア市場規模2015-2020 ・バイオシミラーのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・バイオシミラーの製造コスト分析 ・販売チャネル、流通業者、顧客 ・バイオシミラーの市場動向・機会・課題 ・調査の結論 |
A biosimilar is a biologic medical product highly similar to another already approved biological medicine (the ‘reference medicine’). Biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are officially approved versions of original “innovator” products and can be manufactured when the original product’s patent expires. Reference to the innovator product is an integral component of the approval.
Market Analysis and Insights: Global Biosimilars Market
The global Biosimilars market size is projected to reach US$ 15920 million by 2026, from US$ 5904.6 million in 2020, at a CAGR of 18.0% during 2021-2026.
Global Biosimilars Scope and Market Size
The global Biosimilars market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Biosimilars market is segmented into
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Peptides (Glucagon, Calcitonin)
Segment by Application, the Biosimilars market is segmented into
Oncology
Blood Disorders
The Biosimilars market is analysed and market size information is provided by regions (countries). Segment by Application, the Biosimilars market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biosimilars Market Share Analysis
Biosimilars market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilars business, the date to enter into the Biosimilars market, Biosimilars product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Novartis
Teva Pharmaceuticals Industries
Amgen
Biocon
Dr. Reddy’s Laboratories
Roche Holding
Celltrion
Samsung BioLogics
1 Biosimilars Market Overview
1.1 Biosimilars Product Scope
1.2 Biosimilars Segment by Type
1.2.1 Global Biosimilars Sales by Type (2020-2026)
1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
1.2.4 Peptides (Glucagon, Calcitonin)
1.3 Biosimilars Segment by Application
1.3.1 Global Biosimilars Sales Comparison by Application (2020-2026)
1.3.2 Oncology
1.3.3 Blood Disorders
1.4 Biosimilars Market Estimates and Forecasts (2015-2026)
1.4.1 Global Biosimilars Sales Growth Rate (2015-2026)
1.4.2 Global Biosimilars Revenue and Growth Rate (2015-2026)
1.4.3 Global Biosimilars Price Trends (2015-2026)
2 Biosimilars Estimate and Forecast by Region
2.1 Global Biosimilars Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Biosimilars Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Biosimilars Sales Market Share by Region (2015-2020)
2.2.2 Global Biosimilars Revenue Market Share by Region (2015-2020)
2.3 Global Biosimilars Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Biosimilars Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Biosimilars Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Biosimilars Estimates and Projections (2015-2026)
2.4.2 Europe Biosimilars Estimates and Projections (2015-2026)
2.4.3 China Biosimilars Estimates and Projections (2015-2026)
2.4.4 Japan Biosimilars Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Biosimilars Estimates and Projections (2015-2026)
2.4.6 India Biosimilars Estimates and Projections (2015-2026)
3 Global Biosimilars Competition Landscape by Players
3.1 Global Top Biosimilars Players by Sales (2015-2020)
3.2 Global Top Biosimilars Players by Revenue (2015-2020)
3.3 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars as of 2019)
3.4 Global Biosimilars Average Price by Company (2015-2020)
3.5 Manufacturers Biosimilars Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Biosimilars Players (Opinion Leaders)
4 Global Biosimilars Market Size by Type
4.1 Global Biosimilars Historic Market Review by Type (2015-2020)
4.1.1 Global Biosimilars Sales Market Share by Type (2015-2020)
4.1.2 Global Biosimilars Revenue Market Share by Type (2015-2020)
4.1.3 Global Biosimilars Price by Type (2015-2020)
4.2 Global Biosimilars Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Biosimilars Sales Forecast by Type (2021-2026)
4.2.2 Global Biosimilars Revenue Forecast by Type (2021-2026)
4.2.3 Global Biosimilars Price Forecast by Type (2021-2026)
5 Global Biosimilars Market Size by Application
5.1 Global Biosimilars Historic Market Review by Application (2015-2020)
5.1.1 Global Biosimilars Sales Market Share by Application (2015-2020)
5.1.2 Global Biosimilars Revenue Market Share by Application (2015-2020)
5.1.3 Global Biosimilars Price by Application (2015-2020)
5.2 Global Biosimilars Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Biosimilars Sales Forecast by Application (2021-2026)
5.2.2 Global Biosimilars Revenue Forecast by Application (2021-2026)
5.2.3 Global Biosimilars Price Forecast by Application (2021-2026)
6 United States Biosimilars Market Facts & Figures
6.1 United States Biosimilars Sales Market Share by Company (2015-2020)
6.2 United States Biosimilars Sales Market Share by Type (2015-2020)
6.3 United States Biosimilars Sales Market Share by Application (2015-2020)
7 Europe Biosimilars Market Facts & Figures
7.1 Europe Biosimilars Sales Market Share by Company (2015-2020)
7.2 Europe Biosimilars Sales Market Share by Type (2015-2020)
7.3 Europe Biosimilars Sales Market Share by Application (2015-2020)
8 China Biosimilars Market Facts & Figures
8.1 China Biosimilars Sales Market Share by Company (2015-2020)
8.2 China Biosimilars Sales Market Share by Type (2015-2020)
8.3 China Biosimilars Sales Market Share by Application (2015-2020)
9 Japan Biosimilars Market Facts & Figures
9.1 Japan Biosimilars Sales Market Share by Company (3015-3030)
9.2 Japan Biosimilars Sales Market Share by Type (2015-2020)
9.3 Japan Biosimilars Sales Market Share by Application (2015-2020)
10 Southeast Asia Biosimilars Market Facts & Figures
10.1 Southeast Asia Biosimilars Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Biosimilars Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Biosimilars Sales Market Share by Application (2015-2020)
11 India Biosimilars Market Facts & Figures
11.1 India Biosimilars Sales Market Share by Company (2015-2020)
11.2 India Biosimilars Sales Market Share by Type (2015-2020)
11.3 India Biosimilars Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Biosimilars Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Biosimilars Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Biosimilars Products Offered
12.2.5 Novartis Recent Development
12.3 Teva Pharmaceuticals Industries
12.3.1 Teva Pharmaceuticals Industries Corporation Information
12.3.2 Teva Pharmaceuticals Industries Business Overview
12.3.3 Teva Pharmaceuticals Industries Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Teva Pharmaceuticals Industries Biosimilars Products Offered
12.3.5 Teva Pharmaceuticals Industries Recent Development
12.4 Amgen
12.4.1 Amgen Corporation Information
12.4.2 Amgen Business Overview
12.4.3 Amgen Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Amgen Biosimilars Products Offered
12.4.5 Amgen Recent Development
12.5 Biocon
12.5.1 Biocon Corporation Information
12.5.2 Biocon Business Overview
12.5.3 Biocon Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Biocon Biosimilars Products Offered
12.5.5 Biocon Recent Development
12.6 Dr. Reddy’s Laboratories
12.6.1 Dr. Reddy’s Laboratories Corporation Information
12.6.2 Dr. Reddy’s Laboratories Business Overview
12.6.3 Dr. Reddy’s Laboratories Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Dr. Reddy’s Laboratories Biosimilars Products Offered
12.6.5 Dr. Reddy’s Laboratories Recent Development
12.7 Roche Holding
12.7.1 Roche Holding Corporation Information
12.7.2 Roche Holding Business Overview
12.7.3 Roche Holding Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Roche Holding Biosimilars Products Offered
12.7.5 Roche Holding Recent Development
12.8 Celltrion
12.8.1 Celltrion Corporation Information
12.8.2 Celltrion Business Overview
12.8.3 Celltrion Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Celltrion Biosimilars Products Offered
12.8.5 Celltrion Recent Development
12.9 Samsung BioLogics
12.9.1 Samsung BioLogics Corporation Information
12.9.2 Samsung BioLogics Business Overview
12.9.3 Samsung BioLogics Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Samsung BioLogics Biosimilars Products Offered
12.9.5 Samsung BioLogics Recent Development
13 Biosimilars Manufacturing Cost Analysis
13.1 Biosimilars Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Biosimilars
13.4 Biosimilars Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Biosimilars Distributors List
14.3 Biosimilars Customers
15 Market Dynamics
15.1 Biosimilars Market Trends
15.2 Biosimilars Opportunities and Drivers
15.3 Biosimilars Market Challenges
15.4 Biosimilars Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Biosimilars Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Biosimilars Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Biosimilars Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Biosimilars Sales (K MT) by Region (2015-2020)
Table 5. Global Biosimilars Sales Market Share by Region (2015-2020)
Table 6. Global Biosimilars Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Biosimilars Revenue Share by Region (2015-2020)
Table 8. Global Biosimilars Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Biosimilars Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Biosimilars Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Biosimilars Revenue Share Forecast by Region (2021-2026)
Table 12. Global Biosimilars (K MT) of Key Companies (2015-2020)
Table 13. Global Biosimilars Sales Share by Company (2015-2020)
Table 14. Global Biosimilars Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Biosimilars Revenue Share by Company (2015-2020)
Table 16. Global Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars as of 2019)
Table 17. Global Biosimilars Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Biosimilars Manufacturing Sites and Area Served
Table 19. Manufacturers Biosimilars Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Biosimilars Players
Table 22. Global Biosimilars Sales (K MT) by Type (2015-2020)
Table 23. Global Biosimilars Sales Share by Type (2015-2020)
Table 24. Global Biosimilars Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Biosimilars Price (K MT) by Type (2015-2020)
Table 26. Global Biosimilars Sales Share by Type (2021-2026)
Table 27. Global Biosimilars Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Biosimilars Revenue Share by Type (2021-2026)
Table 29. Global Biosimilars Price (K MT) by Type (2021-2026)
Table 30. Global Biosimilars Sales (K MT) by Application (2015-2020)
Table 31. Global Biosimilars Sales Share by Application (2015-2020)
Table 32. Global Biosimilars Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Biosimilars Price (K MT) by Application (2015-2020)
Table 34. Global Biosimilars Sales (K MT) by Application (2021-2026)
Table 35. Global Biosimilars Sales Share by Application (2021-2026)
Table 36. Global Biosimilars Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Biosimilars Revenue Share by Application (2021-2026)
Table 38. Global Biosimilars Price (K MT) by Application (2021-2026)
Table 39. United States Biosimilars Sales (K MT) by Company (2015-2020)
Table 40. United States Biosimilars Sales Market Share by Company (2015-2020)
Table 41. United States Biosimilars Sales (K MT) by Type (2015-2020)
Table 42. United States Biosimilars Sales Market Share by Type (2015-2020)
Table 43. United States Biosimilars Sales (K MT) by Application (2015-2020)
Table 44. United States Biosimilars Sales Market Share by Application (2015-2020)
Table 45. Europe Biosimilars Sales (K MT) by Company (2015-2020)
Table 46. Europe Biosimilars Sales Market Share by Company (2015-2020)
Table 47. Europe Biosimilars Sales (K MT) by Type (2015-2020)
Table 48. Europe Biosimilars Sales Market Share by Type (2015-2020)
Table 49. Europe Biosimilars Sales (K MT) by Application (2015-2020)
Table 50. Europe Biosimilars Sales Market Share by Type (2015-2020)
Table 51. China Biosimilars Sales (K MT) by Company (2015-2020)
Table 52. China Biosimilars Sales Market Share by Company (2015-2020)
Table 53. China Biosimilars Sales (K MT) by Type (2015-2020)
Table 54. China Biosimilars Sales Market Share by Type (2015-2020)
Table 55. China Biosimilars Sales (K MT) by Application (2015-2020)
Table 56. China Biosimilars Sales Market Share by Application (2015-2020)
Table 57. Japan Biosimilars Sales (K MT) by Company (2015-2020)
Table 58. Japan Biosimilars Sales Market Share by Company (2015-2020)
Table 59. Japan Biosimilars Sales (K MT) by Type (2015-2020)
Table 60. Japan Biosimilars Sales Market Share by Type (2015-2020)
Table 61. Japan Biosimilars Sales (K MT) by Application (2015-2020)
Table 62. Japan Biosimilars Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Biosimilars Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Biosimilars Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Biosimilars Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Biosimilars Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Biosimilars Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Biosimilars Sales Market Share by Application (2015-2020)
Table 69. India Biosimilars Sales (K MT) by Company (2015-2020)
Table 70. India Biosimilars Sales Market Share by Company (2015-2020)
Table 71. India Biosimilars Sales (K MT) by Type (2015-2020)
Table 72. India Biosimilars Sales Market Share by Type (2015-2020)
Table 73. India Biosimilars Sales (K MT) by Application (2015-2020)
Table 74. India Biosimilars Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Pfizer Biosimilars Product
Table 79. Pfizer Recent Development
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Novartis Biosimilars Product
Table 84. Novartis Recent Development
Table 85. Teva Pharmaceuticals Industries Corporation Information
Table 86. Teva Pharmaceuticals Industries Description and Business Overview
Table 87. Teva Pharmaceuticals Industries Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Teva Pharmaceuticals Industries Biosimilars Product
Table 89. Teva Pharmaceuticals Industries Recent Development
Table 90. Amgen Corporation Information
Table 91. Amgen Description and Business Overview
Table 92. Amgen Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Amgen Biosimilars Product
Table 94. Amgen Recent Development
Table 95. Biocon Corporation Information
Table 96. Biocon Description and Business Overview
Table 97. Biocon Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Biocon Biosimilars Product
Table 99. Biocon Recent Development
Table 100. Dr. Reddy’s Laboratories Corporation Information
Table 101. Dr. Reddy’s Laboratories Description and Business Overview
Table 102. Dr. Reddy’s Laboratories Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Dr. Reddy’s Laboratories Biosimilars Product
Table 104. Dr. Reddy’s Laboratories Recent Development
Table 105. Roche Holding Corporation Information
Table 106. Roche Holding Description and Business Overview
Table 107. Roche Holding Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Roche Holding Biosimilars Product
Table 109. Roche Holding Recent Development
Table 110. Celltrion Corporation Information
Table 111. Celltrion Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Celltrion Description and Business Overview
Table 113. Celltrion Biosimilars Product
Table 114. Celltrion Recent Development
Table 115. Samsung BioLogics Corporation Information
Table 116. Samsung BioLogics Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Samsung BioLogics Description and Business Overview
Table 118. Samsung BioLogics Biosimilars Product
Table 119. Samsung BioLogics Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Biosimilars Distributors List
Table 123. Biosimilars Customers List
Table 124. Biosimilars Market Key Trends
Table 125. Biosimilars Key Opportunities and Drivers
Table 126. Biosimilars Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilars Product Picture
Figure 2. Global Biosimilars Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Biosimilars Market Share by Application in 2020 & 2026
Figure 6. Oncology Examples
Figure 7. Blood Disorders Examples
Figure 8. Global Biosimilars Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Biosimilars Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Biosimilars Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Biosimilars Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Biosimilars Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Biosimilars Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Biosimilars Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Biosimilars Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Biosimilars Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Biosimilars Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Biosimilars Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Biosimilars Players Market Share by Revenue in Biosimilars 2015 & 2019
Figure 26. Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Biosimilars Revenue Share by Type (2015-2020)
Figure 28. Global Biosimilars Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Biosimilars Revenue Share by Application (2015-2020)
Figure 30. Global Biosimilars Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Biosimilars Sales Market Share by Type in 2019
Figure 32. United States Biosimilars Sales Market Share by Type in 2019
Figure 33. Europe Biosimilars Sales Market Share by Company in 2019
Figure 34. Europe Biosimilars Sales Market Share by Type in 2019
Figure 35. Europe Biosimilars Sales Market Share by Application in 2019
Figure 36. China Biosimilars Sales Market Share by Company in 2019
Figure 37. China Biosimilars Sales Market Share by Type in 2019
Figure 38. China Biosimilars Sales Market Share by Application in 2019
Figure 39. Japan Biosimilars Sales Market Share by Company in 2019
Figure 40. Japan Biosimilars Sales Market Share by Type in 2019
Figure 41. Japan Biosimilars Sales Market Share by Application in 2019
Figure 42. Southeast Asia Biosimilars Sales Market Share by Company in 2019
Figure 43. Southeast Asia Biosimilars Sales Market Share by Type in 2019
Figure 44. Southeast Asia Biosimilars Sales Market Share by Application in 2019
Figure 45. India Biosimilars Sales Market Share by Company in 2019
Figure 46. India Biosimilars Sales Market Share by Type in 2019
Figure 47. India Biosimilars Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Biosimilars
Figure 50. Manufacturing Process Analysis of Biosimilars
Figure 51. Biosimilars Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
組換えグリコシル化タンパク質の世界市場レポート2020 Market Analysis and Insights: Global Recombinant Glycosylated Protein Market The global Recombinant Glycosylated Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Recombinant Glycosylated Protein Scope and Market …- 組換え非グリコシル化タンパク質の世界市場レポート2020 Market Analysis and Insights: Global Recombinant Non-glycosylated Protein Market The global Recombinant Non-glycosylated Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Recombinant Non-glycosylated Protein Scope…
- グルカゴン様ペプチド-1（GLP-1）アゴニストの世界市場レポート2020 Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia. Un…
- コラーゲンペプチドの世界市場レポート2020 Collagen peptides are a versatile source of protein and an important element of healthy nutrition. One of the major drivers for this market is Demand for collagen peptide in nutrition-based products. Collagen peptide is extensively used in the nutrition-based food industry due to its high protein co…
- 抗菌ペプチドの世界市場レポート2020 Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, bro…